'Dead Jaw' Linked to Fosamax

For many older women, osteoporosis is a much-feared condition of bone loss. Merck & Company, the manufacturer, has widely promoted Fosamax as a bone strengthener. Dentists began to notice, however, that women taking Fosamax can suffer from osteonecrosis or "dead jaw," a deterioration of the jaw bone.

As one doctor said, rather than strengthen bones, Fosamax hardens bones and makes them more brittle. In the jaw, teeth begin to loosen and fall out. Bone tissue dies and fails to regenerate. The condition is painful and can require jaw replacement.

The Fosamax case reminds our lawyers of Vioxx.

Girardi | Keese in California was the first law firm to file a lawsuit against the painkiller Vioxx, a drug that was withdrawn from the market in 2004. Merck, the manufacturer of Vioxx and Fosamax, fights vigorously against any evidence that the company's drugs are defective. Our product liability attorneys have stood up to Merck in the Vioxx case and we are doing the same with Fosamax.

Merck has worked hard to build a market for Fosamax. They have even gone into the business of building equipment to measure bone density. Their equipment is used to show evidence of osteoporosis - and a need for Fosamax.

The list of Fosamax side effects is long, including a higher risk of atrial fibrillation that can lead to congestive heart failure. Studies also report severe digestive reactions, chest pains, esophagus problems, blood clotting disorders, numbness in the face, seizures.

To discuss the Fosamax lawsuit, contact us for an appointment.